Sign in
Taking people in United StatesNo phase

Effects of Transcutaneous Vagal Nerve Stimulation on Post-Surgical Return to Consciousness, Delirium, and Depression

Key facts

Who runs it
Northwestern University
Where
Chicago, United StatesSee the site
Trial code
Status
Recruiting
People taking part
40 people, planned
Started
23 Apr 2026
Expected to end
31 May 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transcutaneous vagal nerve stimulation
  • Sham (No Treatment)
Record updated
28 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Aged > 18 years of age
  • Patients undergoing lumbar surgery for degenerative disc disease or spinal stenosis involving two or more levels
  • Montreal Cognitive Assessment (MoCA) score ≥ 18 - accept mild
  • Ability to use a keyboard
  • Able to understand and communicate in English
  • Be able to consent independently
  • Women of child-bearing age must be comfortable confirming a negative pregnancy prior to participating in the study
  • Must not be involved in any other research intervention study testing neurobehavioral functioning

Who cannot take part

  • History of vagotomy (cutting the vagus nerve)
  • History of seizure disorder or intracranial hemorrhage
  • Other neurological diagnoses or a diagnosis of severe psychiatric disorder (e.g., psychosis) or a reported childhood learning disability
  • ECG adhesive allergy
  • History of bradycardia, heart block, prolonged QT syndrome, brugada syndrome, heart failure with ejection fraction less than 35% and/or New York Heart Association symptoms
  • Age < 18 years of age
  • MoCA < 18
  • Patients with carotid stenosis
  • Patients with aneurysms
  • Pregnancy, breastfeeding
  • Active addiction history
  • Severe aphasia, preventing subject from understanding the protocol and giving written consent
  • Patients will be excluded postoperatively if there is neck swelling at the proposed site of left tcVNS

Where in United States

  • Northwestern University Feinberg School of MedicineChicago, United StatesContact: Jordan Wood, BSTaking people

About the trial

What the trial wants to find out

This study will examine whether noninvasive, transcutaneous vagal nerve stimulation (tcVNS) can help restore consciousness in patients in the operating room and the Post Anesthesia Care Unit (PACU). The study will also investigate if tcVNS can expedite discharge from the PACU and examine whether tcVNS administerd in the PACU helps reduce delirium and depression after surgery. The study will also evaluate whether tcVNS speeds cognitive recovery from emergence of anesthesia and surgery.

The 2 groups in the trial

  • tcVNS Stimulation (Intervention)Existing treatment, for comparison

    Transcutaneous vagal nerve stimulation (tcVNS)

    Treatment: Transcutaneous vagal nerve stimulation

  • Sham tcVNS stimulation (Control)Sham treatment, for comparison

    Sham transcutaneous vagal nerve stimulation (Sham tcVNS)

    Treatment: Sham (No Treatment)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
28 May 2026